Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRA
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu Logo Principal Oniris

Home page

Living Lab Prudent use of antibiotics in pig and poultry farming

Living Lab Prudent use of antibiotics in pig and poultry farming
A Living Lab bringing together the Ministry of Agriculture (DGAl), veterinary authorities (order, trade union, technical organisations) and the interprofessions and technical institutes of the French pig and poultry sectors was set up within the framework of the H2020 project ROADMAP (Rethinking Of Antimicrobial Decision systems in the Management of Animal Production, https://www.roadmap-h2020.eu). The ImpresS ex ante method developed by CIRAD facilitates the participatory process to define the scope of the group's action and to build strategies that will enable progress to be made towards a virtuous use of antibiotics (towards 'better' rather than just 'less') and that will guarantee the health and well-being of the animals, the sustainability of these sectors and of the veterinary network on the territory. The selected strategies will be validated in collaboration with other stakeholders (distributors, consumers). This work is in line with national and European measures governing the use of antibiotics in veterinary medicine (Ecoantibio plan, One Health interministerial roadmap, regulatory obligation to report data on the sale and use of antibiotics) and will be integrated into the construction of the Ministry of Agriculture's EcoAntibio 3 plan.

Context and issues

Within the framework of the H2020 project ROADMAP (Rethinking Of Antimicrobial Decision systems in the Management of Animal Production) coordinated by INRAE (https://www.roadmap-h2020.eu), twelve Living Labs aiming at co-constructing strategies for a more prudent use of antibiotics have been set up. In France, one of these participatory schemes concerns pig and poultry farms, where the use of antibiotics has been greatly reduced but where it is no longer appropriate to consider only the quantitative aspect. Indeed, in these sectors, "antibiotic-free" labels or charters have emerged which may constitute an attack on the health and well-being of animals by preventing the therapeutic use of antibiotics on sick animals. This Living Lab brings together the Ministry of Agriculture (DGAl), veterinary authorities (order, trade union, technical organisations) and the interprofessions and technical institutes of the pig and poultry sectors. The ImpresS ex ante method developed by CIRAD is used to facilitate the participatory process.

Results

The stages of the ImpresS ex ante process are carried out through meetings (two already organised, two to come in the first quarter of 2022) with the aim of identifying collective strategies to be implemented. A sytemic analysis of the intervention context has been conducted and a shared and desirable vision of the future for the prudent use of anitibiotics has been formulated (this includes a set of common intentions and a variety of desirable impacts). The field of action of the collective's intervention (i.e. over which it has legitimacy) was defined to serve as a basis for the construction of the strategies necessary for the success of the intervention. The strategies will be selected by the stakeholders because they are likely to enable progress to be made towards a virtuous use of antibiotics (towards "better" rather than just "less") that will guarantee the health and well-being of the animals, the sustainability of these sectors and of the veterinary network in the region.

Perspectives

An extension of the group to other stakeholders (distributors, consumers) is envisaged to validate the selected strategies. The implementation of these strategies will lead to specific research projects.

Valorisation

In addition to scientific publications and other communication media on the results of this participatory process, this work will contribute to version 3 of the Ecoantibio plan, the construction of which will begin in 2022 at the same time as the revision of the interministerial roadmap One Health. Similarly, this work will feed into the reflection on the means implemented to respond to the European regulation that requires the reporting of data on the sale and use of antibiotics.